a clinical stage biopharmaceutical company with interest in the development of novel allogeneic drugs
Industry Biotechnology
A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with FENC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then FENC could also see price increases.
| Ticker / NAME | Correlation To SCPX | 1D Price Change % | ||
|---|---|---|---|---|
| SCPX | 100% | -1.82% | ||
| FENC - SCPX | 40% Loosely correlated | +2.02% | ||
| ENTO - SCPX | 39% Loosely correlated | -3.95% | ||
| CABA - SCPX | 35% Loosely correlated | +1.48% | ||
| OVID - SCPX | 33% Loosely correlated | +0.95% | ||
| AVTE - SCPX | 33% Poorly correlated | N/A | ||
More | ||||